Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature
Author(s):
Melief, S.M.; Visconti, V.V.; Visser, M.; Diepen, M. van; Kapiteijn, E.H.W.; Berg, J.H. van den; Haanen, J.B.A.G.; Smit, V.T.H.B.M. (0000-0003-3730-5652); Oosting, J.; Burg, S.H. van der (0000-0002-6556-0354); Verdegaal, E.M.E. (0000-0002-4449-8707)
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-02-28
Language
English
Is part of
Cancer Immunology Research (2017), Vol. 5, no. 2, p. 170-179
